Journal rankings · indicator year 2003
Choose a field to open its ranking, or a journal to find its row in its subfield’s list.
Subfield ranking · 2003
Infectious Diseases journal rankings 2003
82 ranked journals · Subfield in Medicine
Infectious Diseases has 82 ranked journals in 2003. The median OJR fell 0.07 on 2002 to 0.76, below the world average of 1.00; Q1 starts at OJR 1.36. The top three are New England Journal of Medicine, Clinical Microbiology Reviews, and Annals of Internal Medicine.
Ranks and citation indicators: 2003. Journal access status and listed APC: source snapshot September 23, 2026.
Journals whose main subfield sits in this category and that published at least 30 citable documents (articles, reviews and conference papers) in 2000–2002, the window the 2003 score is computed on.
The OpenJournalRank Indicator (OJR) is a free, publicly available metric of a journal’s field-normalized citation impact, computed from open OpenAlex citation data. It compares citations to a journal’s papers from the previous three years with the world average for papers of the same subfield, year and type, so 1.00 is the world average and values can be compared across fields. It is computed with the NCI3 method.
The middle OJR among ranked journals in this category: half score higher, half lower. 1.00 is the world average for papers of the same subfield, year and type.
The dot is this category, the solid tick is the median of all ranked journals and the dashed line is the world average.
Share of ranked journals in this category that are fully open access, so every paper is free to read. Hybrid journals, which sell subscriptions and open single papers for a fee, are not counted.
Median list price of the article processing charge, in US dollars, among ranked journals in this category that list a price above zero. Journals with a listed APC of $0 and journals with no known price are left out of this median. The At a glance table below gives a second median that includes the $0 prices.
Subfields of Medicine (42)
- Surgery378
- Pulmonary and Respiratory Medicine140
- Cardiology and Cardiovascular Medicine128
- Public Health, Environmental and Occupational Health128
- Oncology103
- Epidemiology89
- Infectious Diseases82
- Psychiatry and Mental health82
- Radiology, Nuclear Medicine and Imaging69
- Neurology68
- Physiology67
- Endocrinology, Diabetes and Metabolism60
Show all 42 subfields
- Hematology48
- Dermatology47
- Orthopedics and Sports Medicine47
- Pediatrics, Perinatology and Child Health47
- Ophthalmology41
- Obstetrics and Gynecology39
- Nephrology27
- Pharmacology27
- Rheumatology27
- Emergency Medicine22
- Reproductive Medicine22
- Otorhinolaryngology18
- Complementary and alternative medicine17
- Rehabilitation16
- Pathology and Forensic Medicine15
- Geriatrics and Gerontology13
- Immunology and Allergy13
- Critical Care and Intensive Care Medicine12
- Anesthesiology and Pain Medicine8
- Genetics8
- Hepatology7
- Gastroenterology6
- Urology5
- Internal Medicine3
- Transplantation2
- Biochemistry1
- Family Practice1
- Anatomy0
- Health Informatics0
- Microbiology0
82 ranked journals
Filters
Rank is the position by OJR within the list on screen; 1 is the highest. | OJR is field-normalized 3-year citation impact: 1.00 is the world average for papers of the same subfield, year and type, so values compare across fields. The badge is the journal’s quartile in this list. | Citations per paper over a two-year window, counted from OpenAlex. It is not field-normalized, so compare it only between journals of the same field. ▲ or ▼ is the change from 2002. This is OpenJournalRank’s own count, not Clarivate’s Journal Impact Factor. | Citable documents (articles, reviews and conference papers) published in 2000–2002, the window the 2003 OJR is computed on. A journal needs at least 30 to be ranked. | Share of the journal’s 2000–2002 papers that are free to read in any open-access form. The green OA tag next to a title marks a fully open-access journal. | List price of the article processing charge in US dollars. “$0 listed” means the listed price is zero; a dash means no price is listed. | The line is the journal’s OJR from 2000 to 2003. | Compare |
|---|---|---|---|---|---|---|---|
1New England Journal of MedicineMassachusetts Medical Society · United States | 9.91Q1 | 19.03 1.86 up from 2002 | 2,518 | 25% | — | ||
2Clinical Microbiology ReviewsAmerican Society for Microbiology · United States | 7.23Q1 | 13.86 3.72 up from 2002 | 151 | 100% | — | ||
3Annals of Internal MedicineAmerican College of Physicians · United States | 3.76Q1 | 6.83 0.87 up from 2002 | 1,316 | 1% | — | ||
4The Lancet Infectious DiseasesElsevier BV · Netherlands | 3.66Q1 | 7.35 3.18 up from 2002 | 123 | 15% | $7,280 | ||
5Clinical Infectious DiseasesOxford University Press · United States | 2.65Q1 | 5.11 0.64 up from 2002 | 2,089 | 26% | $4,763 | ||
6Emerging infectious diseasesOACenters for Disease Control and Prevention · United States | 2.39Q1 | 4.88 1.15 up from 2002 | 827 | 100% | — | ||
7The Journal of Infectious DiseasesOxford University Press · United States | 2.36Q1 | 4.98 0.24 down from 2002 | 1,955 | 41% | $4,763 | ||
8Antimicrobial Agents and ChemotherapyOAAmerican Society for Microbiology · United States | 1.98Q1 | 4.49 0.07 down from 2002 | 2,115 | 100% | — | ||
9AIDSLippincott Williams & Wilkins · United Kingdom | 1.98Q1 | 4.85 0.25 down from 2002 | 1,540 | 2% | — | ||
10Microbes and InfectionElsevier BV · France | 1.91Q1 | 4.39 0.98 up from 2002 | 530 | 95% | $3,510 | ||
11Reviews in Medical VirologyWiley · United Kingdom | 1.88Q1 | 4.21 0.06 up from 2002 | 110 | 5% | $4,880 | ||
12Journal of Clinical MicrobiologyOAAmerican Society for Microbiology · United States | 1.81Q1 | 3.84 0.15 up from 2002 | 2,831 | 99% | — | ||
13Antiviral TherapyOASAGE Publishing · United Kingdom | 1.71Q1 | 3.81 0.24 down from 2002 | 103 | 64% | $2,800 | ||
14Journal of General VirologyMicrobiology Society · United Kingdom | 1.61Q1 | 3.44 0.13 down from 2002 | 922 | 7% | — | ||
15Journal of Antimicrobial ChemotherapyOxford University Press · United Kingdom | 1.49Q1 | 3.01 0.02 up from 2002 | 1,226 | 25% | $3,784 | ||
16Antiviral ResearchElsevier BV · Netherlands | 1.42Q1 | 3.48 0.86 up from 2002 | 226 | 5% | $4,160 | ||
17AIDS CareTaylor & Francis · United Kingdom | 1.40Q1 | 1.70 0.16 down from 2002 | 134 | 24% | — | ||
18Tropical Medicine & International HealthWiley · United Kingdom | 1.39Q1 | 2.49 0.45 up from 2002 | 408 | 48% | $3,400 | ||
19AIDS Education and PreventionGuilford Press · United States | 1.37Q1 | 1.41 0.03 down from 2002 | 150 | 5% | — | ||
20British Journal of Clinical PharmacologyWiley · United Kingdom | 1.36Q1 | 2.45 0.11 up from 2002 | 647 | 92% | $4,780 | ||
21American Journal of Infection ControlElsevier BV · United States | 1.36Q1 | 2.54 0.74 up from 2002 | 259 | 16% | $3,360 | ||
22Epidemiology and InfectionOACambridge University Press · United Kingdom | 1.26Q2 | 2.03 0.02 up from 2002 | 428 | 100% | $3,550 | ||
23Medical MycologyOxford University Press · United Kingdom | 1.25Q2 | 2.29 0.01 up from 2002 | 283 | 36% | $4,889 | ||
24Journal of Medical VirologyWiley · United States | 1.23Q2 | 2.59 0.08 down from 2002 | 758 | 6% | $4,730 | ||
25HIV MedicineWiley · United Kingdom | 1.21Q2 | 3.12 1.82 up from 2002 | 108 | 53% | $4,150 | ||
26Diagnostic Microbiology and Infectious DiseaseElsevier BV · United States | 1.11Q2 | 2.35 0.39 up from 2002 | 422 | 1% | $3,290 | ||
27International Journal of Medical MicrobiologyOAElsevier BV · Germany | 1.07Q2 | 2.08 0.02 up from 2002 | 270 | 5% | $3,410 | ||
28Clinical Microbiology and InfectionElsevier BV · United Kingdom | 1.06Q2 | 2.56 1.51 up from 2002 | 556 | 98% | $3,780 | ||
29Viral ImmunologyMary Ann Liebert, Inc. · United States | 1.05Q2 | 2.44 0.40 up from 2002 | 132 | 0% | — | ||
30JAIDS Journal of Acquired Immune Deficiency SyndromesLippincott Williams & Wilkins · United States | 1.04Q2 | 2.46 0.06 up from 2002 | 1,449 | 4% | — | ||
31Journal of Medical MicrobiologyMicrobiology Society · United Kingdom | 1.04Q2 | 1.87 0.14 up from 2002 | 269 | 7% | — | ||
32Journal of Virological MethodsElsevier BV · Netherlands | 1.01Q2 | 2.16 0.11 up from 2002 | 501 | 5% | $3,210 | ||
33Virus ResearchOAElsevier BV · Netherlands | 0.98Q2 | 1.94 0.29 up from 2002 | 412 | 7% | $3,010 | ||
34Journal of Hospital InfectionElsevier BV · United Kingdom | 0.90Q2 | 1.80 0.05 up from 2002 | 560 | 3% | $4,000 | ||
35International Journal of STD & AIDSSAGE Publishing · United Kingdom | 0.90Q2 | 1.26 0.08 up from 2002 | 185 | 1% | $4,150 | ||
36Infection Control and Hospital EpidemiologyCambridge University Press · United Kingdom | 0.86Q2 | 0.92 0.26 down from 2002 | 1,032 | 23% | $3,550 | ||
37TuberculosisElsevier BV · United Kingdom | 0.86Q2 | 2.00 0.05 up from 2002 | 66 | 1% | $2,690 | ||
38FEMS Immunology & Medical MicrobiologyOxford University Press · Netherlands | 0.84Q2 | 1.53 0.02 up from 2002 | 458 | 69% | — | ||
39Journal of InfectionOAElsevier BV · United Kingdom | 0.83Q2 | 1.35 0.14 down from 2002 | 400 | 2% | $4,030 | ||
40AIDS and BehaviorSpringer Science+Business Media · Netherlands | 0.79Q2 | 0.99 0.14 up from 2002 | 113 | 3% | $4,590 | ||
41AIDS Research and Human RetrovirusesMary Ann Liebert, Inc. · United States | 0.77Q2 | 2.47 0.01 up from 2002 | 623 | 4% | — | ||
42InfectionSpringer Science+Business Media · Germany | 0.75Q3 | 1.20 0.15 up from 2002 | 247 | 6% | $4,790 | ||
43Infection Genetics and EvolutionOAElsevier BV · Netherlands | 0.71Q3 | 1.31 0.19 up from 2002 | 52 | 7% | $2,730 | ||
44HIV Clinical TrialsTaylor & Francis · United Kingdom | 0.71Q3 | 1.85no change | 119 | 86% | — | ||
45Medical Microbiology and ImmunologySpringer Science+Business Media · Germany | 0.69Q3 | 1.30 0.10 down from 2002 | 40 | 4% | $5,090 | ||
46Scandinavian Journal of Infectious DiseasesInforma · United Kingdom | 0.65Q3 | 1.08 0.09 up from 2002 | 668 | 3% | — | ||
47MycopathologiaSpringer Science+Business Media · Netherlands | 0.65Q3 | 1.06 0.43 up from 2002 | 162 | 3% | $4,190 | ||
48AIDS Patient Care and STDsMary Ann Liebert, Inc. · United States | 0.63Q3 | 1.36 0.34 up from 2002 | 230 | 0% | — | ||
49ApmisWiley · United Kingdom | 0.58Q3 | 1.04 0.08 down from 2002 | 377 | 10% | $4,460 | ||
50BMC Infectious DiseasesOABioMed Central · United Kingdom | 0.56Q3 | 1.40 0.15 up from 2002 | 55 | 100% | $3,090 |
Subfields of Medicine, with Infectious Diseases highlighted.
- Surgery378
- Pulmonary and Respiratory Medicine140
- Cardiology and Cardiovascular Medicine128
- Public Health, Environmental and Occupational Health128
- Oncology103
- Epidemiology89
- Infectious Diseases82
- Psychiatry and Mental health82
- Radiology, Nuclear Medicine and Imaging69
- Neurology68
- Physiology67
- Endocrinology, Diabetes and Metabolism60
- Hematology48
- Dermatology47
- Orthopedics and Sports Medicine47
- Pediatrics, Perinatology and Child Health47
- Ophthalmology41
- Obstetrics and Gynecology39
- Nephrology27
- Pharmacology27
- Rheumatology27
- Emergency Medicine22
- Reproductive Medicine22
- Otorhinolaryngology18
- Complementary and alternative medicine17
- Rehabilitation16
- Pathology and Forensic Medicine15
- Geriatrics and Gerontology13
- Immunology and Allergy13
- Critical Care and Intensive Care Medicine12
- Anesthesiology and Pain Medicine8
- Genetics8
- Hepatology7
- Gastroenterology6
- Urology5
- Internal Medicine3
- Transplantation2
- Biochemistry1
- Family Practice1
- Anatomy0
- Health Informatics0
- Microbiology0
Journals
Citations made in 2003. Corpus-wide, 70.2% of core-journal articles and reviews published that year have at least one matched reference; the share varies by journal and field.
29 additional Infectious Diseases journals with metrics are unranked under this release’s eligibility rules: a journal needs at least 30 citable documents in 2000–2002, at least 80% of them with a subfield, and a positive world-average expectation. Ranks are within the whole category; filters hide rows without re-ranking. OJR excludes self-citations.
At a glance
Indicator year: 2003. Publication window: 2000–2002. How these summaries are calculated
- Ranked journals
- 82
- Window papers (baseline)
- 24,640 +34.1% from indicator year 2000
- Median OJR
- 0.76 +25.7% from indicator year 2000
- Rising journals (2025)
- 48
Window papers are the baseline paper population: citable papers (articles, reviews and conference papers) from 2000–2002 in all journals of the world-average baseline, including non-core journals, counted by each paper’s own subfield. They are not the papers of the ranked journals alone.
| Measure | Year series | 2000 | 2001 | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Ranked journals | 70 | 73 | 78 | 82 | 86 | 92 | 95 | 101 | 106 | 110 | 118 | 131 | 144 | 162 | 173 | 182 | 189 | 198 | 210 | 217 | 222 | 234 | 243 | 259 | 263 | 258 | |
| Window papers (baseline) | 18,375 | 21,167 | 22,805 | 24,640 | 25,208 | 28,008 | 31,333 | 35,063 | 38,170 | 42,272 | 46,364 | 49,515 | 52,080 | 54,445 | 58,513 | 62,728 | 67,259 | 69,548 | 70,742 | 70,658 | 72,743 | 100,768 | 135,954 | 162,915 | 153,103 | 130,899 | |
| Median OJR | 0.602 | 0.68 | 0.82 | 0.76 | 0.77 | 0.901 | 0.98 | 0.93 | 1.04 | 0.998 | 1.01 | 0.999 | 0.97 | 0.900 | 0.91 | 0.874 | 0.85 | 0.8699 | 0.8696 | 0.83 | 0.80 | 0.597 | 0.61 | 0.64 | 0.70 | 0.75 |
How to read these rankings
- OJR, the OpenJournalRank Indicator
- A field-normalized 3-year citation impact, computed from OpenAlex with the NCI3 method. It divides the citations a journal’s papers received by the world average for papers of the same subfield, year and type, so 1.00 is the world average and 2.00 means twice as many citations as expected. Because it is normalized, it can be compared across fields. Read the methodology
- Quartiles
- Q1 to Q4 split the ranked journals of the list you are viewing into four equal groups by OJR. A journal’s quartile depends on the list: the same journal can be Q1 in its subfield and Q2 among all journals.
- Impact factor (2-year)
- Citations per paper over a two-year window, counted from OpenAlex. It is easy to compare with familiar impact factors but is not field-normalized, so compare it only within a field. It is not Clarivate’s Journal Impact Factor. Why it differs from the Journal Impact Factor
- Rank ranges
- Each rank in the latest year carries a likely range from 1,000 resamples of the journal’s papers. Where two journals’ ranges overlap, the data cannot tell them apart, so treat neighbouring ranks as ties.